Area of research
Transplantation · Hepatology
Research interest
Research interests include Renal Transplantation Outcomes and Treatments, Hepatitis C virus research, Organ Transplantation Techniques and Outcomes, and Liver Disease Diagnosis and Treatment.
The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity
Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal
When is it safe to perform abdominal transplantation in patients with prior SARS‐CoV‐2 infection: A case series
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings
KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C
Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low‐dose corticosteroids in primary kidney transplantation: 18‐year results
Kidney Transplantation From a Hepatitis C Virus–Infected Donor Into an Uninfected Recipient: Ready for Prime Time?
Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre‐ and post‐direct‐acting antiviral therapy eras: 10‐Year single center experience
A cluster of donor‐derived <i><scp>C</scp>ryptococcus neoformans</i> infection affecting lung, liver, and kidney transplant recipients: Case report and review of literature
Roux‐en‐Y gastric bypass is an effective bridge to kidney transplantation: Results from a single center
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4–5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial
Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study
Elbasvir/grazoprevir does not worsen renal function in patients with hepatitis C virus infection and pre‐existing renal disease
Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease
Hepatitis C Virus Infection in Chronic Kidney Disease
Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus–Infected Kidney Allograft Recipients
Cost‐effectiveness of elbasvir/grazoprevir use in treatment‐naive and treatment‐experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States
Impact of antiretroviral therapy on clinical outcomes in HIV+ kidney transplant recipients: Review of 58 cases
Randomized trial of rATg/Daclizumab vs. rATg/Alemtuzumab as dual induction therapy in renal transplantation: Results at 8years of follow-up
Direct‐Acting Antiviral Agents for the Hepatitis C Virus‐Infected Chronic Kidney Disease Population: The Dawn of a New Era
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study
Lower tacrolimus trough levels are associated with subsequently higher acute rejection risk during the first 12 months after kidney transplantation
LP02 : C-surfer: grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease
Multivariable risk of developing new onset diabetes after transplant—results from a single‐center study of 481 adult, primary kidney transplant recipients
Graft Failure Due to Noncompliance Among 628 Kidney Transplant Recipients With Long-term Follow-up
Comparison of Mortality of ESRD Patients with Lupus by Initial Dialysis Modality
Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant
Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy
Kidney allograft survival of African American and Caucasian American recipients with lupus
Disparities Among Blacks, Hispanics, and Whites in Time From Starting Dialysis to Kidney Transplant Waitlisting